首页> 外文期刊>BMC Cancer >The influence of radiotherapy techniques on the plan quality and on the risk of secondary tumors in patients with pituitary adenoma
【24h】

The influence of radiotherapy techniques on the plan quality and on the risk of secondary tumors in patients with pituitary adenoma

机译:放射治疗技术对垂体腺瘤患者患者的规模和继发性肿瘤风险的影响

获取原文
           

摘要

This planning study compares different radiotherapy techniques for patients with pituitary adenoma, including flatness filter free mode (FFF), concerning plan quality and secondary malignancies for potentially young patients. The flatness filter has been described as main source of photon scatter. Eleven patients with pituitary adenoma were included. An Elekta Synergy? linac was used in the treatment planning system Oncentra? and for the measurements. 3D plans, IMRT, and VMAT plans and non-coplanar varieties were considered. The plan quality was evaluated regarding homogeneity, conformity, delivery time and dose to the organs at risk. The secondary malignancy risk was calculated from dose volume data and from measured dose to the periphery using different models for carcinoma and sarcoma risk. The homogeneity and conformity were nearly unchanged with and without flattening filter, neither was the delivery time found substantively different. VMAT plans were more homogenous, conformal and faster in delivery than IMRT plans. The secondary cancer risk was reduced with FFF both in the treated region and in the periphery. VMAT plans resulted in a higher secondary brain cancer risk than IMRT plans, but the risk for secondary peripheral cancer was reduced. Secondary sarcoma risk plays a minor role. No advantage was found for non-coplanar techniques. The FFF delivery times were not shortened due to additional monitor units needed and technical limitations. The risk for secondary brain cancer seems to depend on the irradiated volume. Secondary sarcoma risk is much smaller than carcinoma risk in accordance to the results of the atomic bomb survivors. The reduction of the peripheral dose and resulting secondary malignancy risk for FFF is statistically significant. However, it is negligible in comparison to the risk in the treated region. Treatments with FFF can reduce secondary malignancy risk while retaining similar quality as with flattening filter and should be preferred. VMAT plans show the best plan quality combined with lowest peripheral secondary malignancy risk, but highest level of second brain cancer risk. Taking this into account VMAT FFF seems the most advantageous technique for the treatment of pituitary adenomas with the given equipment.
机译:该计划研究比较了垂体腺瘤患者的不同放射治疗技术,包括平坦过滤器自由模式(FFF),关于潜在的年轻患者的计划质量和继发性恶性肿瘤。平坦度过滤器已被描述为光子散射的主要来源。包括11名垂体腺瘤患者。 Elekta Synergy? Linac用于治疗计划系统上incentra?以及测量。 3D计划,IMRT和VMAT计划和非共面品种。对均匀性,符合性,递送时间和风险的器官的剂量评估计划质量。使用不同模型的癌和肉瘤风险,从剂量数据和测量剂量从剂量数据和测量剂量计算次要恶性风险。均匀性和符合性几乎不变,没有扁平滤波器,递送时间也没有实质性地发现。 VMAT计划比IMRT计划更加均匀,保全,更快。在处理区域和外围中,在次要癌症风险减少了FFF。 VMAT计划导致高级脑癌风险高于IMRT计划,但次要外周癌的风险降低。次要肉瘤风险起着小的作用。没有针对非共面技术找到的优势。由于所需的监控单元和技术限制,FFF交付时间不会缩短。继发性脑癌的风险似乎取决于辐照的体积。根据原子弹幸存者的结果,次级肉瘤风险远小于癌症风险。外周剂量的减少并导致FFF的继发性恶性风险是统计学意义。然而,与处理区域的风险相比,它可以忽略不计。使用FFF的治疗可以减少继发性恶性风险,同时保持与扁平化过滤器相似的质量,并且应该是优选的。 VMAT计划显示最佳的计划质量,结合了最低的外周次要恶性肿瘤风险,但第二级脑癌风险最高。考虑到这一点VMAT FFF似乎是用给定的设备治疗垂体腺瘤的最有利的技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号